Form 4: Omeros VP Finance Sells 60,000 Shares After Option Exercise
Insider Transaction Report
Omeros Corp's VP of Finance and CAO, David J. Borges, reported the sale of 60,000 common shares following the exercise of stock options.
Summary
- David J. Borges, VP, Finance & CAO of Omeros Corp (OMER), reported transactions involving the company's common stock and stock options.
- On January 13, 2026, Borges exercised 30,000 stock options at an exercise price of $3.06 per share.
- Immediately following the option exercise on January 13, 2026, Borges sold 30,000 shares of common stock at a weighted average price of $12.3105 per share.
- An additional sale of 30,000 shares of common stock occurred on January 12, 2026, at a weighted average price of $12.72 per share.
- Following these transactions, the reporting person holds 0 shares of common stock directly and 65,000 stock options.
- The stock options have an exercise price of $3.06, vest over 48 equal monthly installments from April 1, 2024, and have an expiration date of April 25, 2034.
- Borges stated that all currently planned sales of Omeros Corporation's common stock have been completed.
Sentiment
Score: 4
Explanation: The sale of a significant number of shares by a key executive, even after exercising options, can be interpreted as a mild negative signal, suggesting profit-taking or diversification rather than strong conviction in immediate future upside. However, the executive still holds a substantial number of unexercised options.
Positives
- The exercise of options indicates a prior belief in the company's value, as the options were significantly in-the-money.
- The reporting person still holds 65,000 unexercised stock options, suggesting continued long-term interest in the company's performance.
Negatives
- An insider selling a significant number of shares (60,000 in total) could be perceived negatively by the market, potentially signaling a desire for diversification or profit-taking.
- The sales occurred at prices ($12.72 and $12.3105) significantly above the option exercise price ($3.06), indicating a profit-taking event.
Future Outlook
NA
Management Comments
- The reporting person has completed all currently planned sales of Omeros Corporation's common stock.
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the insider sale as a signal, potentially influencing short-term sentiment regarding the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Vesting commencement date for stock options. |
| 01/12/2026 | Date of sale of 30,000 common shares by David J. Borges. |
| 01/13/2026 | Date of exercise of 30,000 stock options and subsequent sale of 30,000 common shares by David J. Borges. |
| 01/14/2026 | Signature date of the Form 4 filing. |
| 04/25/2034 | Expiration date of the stock options. |
Recommendation
holdWhile the sale of 60,000 shares by the VP of Finance and CAO could be perceived negatively, it follows the exercise of options, indicating profit-taking. The executive still retains 65,000 unexercised options, suggesting continued alignment with the company's long-term performance. Without additional fundamental analysis of Omeros Corp, a 'hold' recommendation is appropriate, advising investors to monitor future developments and company performance.
Keywords
Omeros Corp, OMER, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, David J. Borges, VP Finance, CAO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.